asa guidelines for glp 1 agonists Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Glucagon-Like Peptide-1 Receptor Agonists–Health Professional
Description
186 VarolCZvibelISpektorLMantelmacherFDVugmanMThurmTet al
Seek immediate medical attention for severe dizziness with loss of consciousness, chest pain, neurological symptoms, or severe abdominal pain
Percentage of Mounjaro Users Experiencing Vision Changes The use of a GLP-1 drug is associated with a fourfold higher risk of NAION when used to treat type 2 diabetes
Safety Considerations and Who Should Avoid Tirzepatide The most common side effects reported in trials were gastrointestinalnausea, vomiting, diarrhea, and constipationtypically mild to moderate and improving over time
